Therapeutic Spotlight: New Evidence Brings Cautious Optimism to Alzheimer’s Disease Treatment
Webinar: Navigating Pre-approval Information Exchange (PIE) and the AMCP Format for Formulary Submissions, Version 4.1
This webinar will provide an overview of pre-approval information exchange (PIE), review the changes and discuss the implications of the recently released AMCP Format v4.1, and provide manufacturer considerations and recommendations for PIE and the pre-approval dossier.
Integration of Patient-Reported Outcomes (PROs) and the Patient Voice: A Review of 6 Health Technology Assessment (HTA) Agencies
The Evolving Healthcare Landscape and the Impact on Patient Access and Affordability
Managing the Growing Expansion of Copay Accumulators
Xcenda Collaborated with MAPRx to Publish New Report Addressing Medicare Part D Challenges to Beneficiaries
Emerging Trends in PBM Restrictions on Commercial Copay Assistance
Applying Cost-Effectiveness Thresholds to the Real World: Implications on Access for Medicare Beneficiaries
Xcenda Examines the Impact of the Tax Cuts and Jobs Act on the Life Science Sector
Xcenda Examines the impact of the Tax Cuts and Jobs Act on the life sciences sector.
Finding the Balance in Pharmaceutical Evidence Exchange With Payers and Providers
Xcenda Conducts Unique Research on Air Medical Services Costs
The Association of Air Medical Services (AAMS) commissioned Xcenda, part of AmerisourceBergen, to conduct independent research on the costs associated with providing emergent air medical transports. The commissioned study is in response to an evident need for reputable, independent research to quantify the costs associated with providing emergent air medical transports.